For several years, the JSR Life Sciences team worked closely with the LFB team at the bioproduction facility in Alès (LFB Biomanufacturing), cumulating in the implementation of the Amsphere™ A3 Protein-A media in clinical Phase II manufacturing of a monoclonal antibody. LFB recently tripled the production capacity of this facility, which also provides biomanufacturing services. The Amsphere™ A3 media offered LFB Biomanufacturing the best productivity, excellent impurity clearance and outstanding process economics in manufacturing scale.